| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
49,310,000 |
| Market
Cap: |
449.71(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.12 - $9.12 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wentworth Kerry |
Chief Regulatory Officer |
• – – |
2018-10-06 |
4/A |
OE |
$0.00 |
$0 |
D/D |
3,400 |
15,878 |
|
- |
|
| Arkowitz David |
Chief Financial Officer |
• – – |
2018-08-09 |
4 |
B |
$23.42 |
$93,680 |
D/D |
4,000 |
44,250 |
2.74 |
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2018-08-09 |
4 |
B |
$22.33 |
$223,300 |
D/D |
10,000 |
75,282 |
2.81 |
- |
|
| Bodick Neil |
Chief Scientific Officer |
• – – |
2018-07-03 |
4 |
AS |
$25.00 |
$412,300 |
D/D |
(16,492) |
62,307 |
|
- |
|
| Bodick Neil |
Chief Scientific Officer |
• – – |
2018-07-02 |
4 |
AS |
$25.10 |
$841,192 |
D/D |
(33,508) |
78,799 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2018-06-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
554 |
294,937 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2018-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
554 |
83,295 |
|
- |
|
| Kelley Scott |
Chief Medical Officer |
• – – |
2018-06-20 |
4 |
A |
$21.22 |
$21,241 |
D/D |
1,001 |
15,893 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2018-06-20 |
4 |
A |
$21.22 |
$11,756 |
D/D |
554 |
65,282 |
|
- |
|
| Wentworth Kerry |
Chief Regulatory Officer |
• – – |
2018-06-20 |
4 |
A |
$21.22 |
$3,629 |
D/D |
171 |
12,478 |
|
- |
|
| Levine Mark S. |
General Counsel |
• – – |
2018-06-20 |
4 |
A |
$21.22 |
$11,438 |
D/D |
539 |
8,872 |
|
- |
|
| Arkowitz David |
Chief Financial Officer |
• – – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
40,250 |
|
- |
|
| Bodick Neil |
Chief Scientific Officer |
• – – |
2018-05-11 |
4 |
OE |
$0.16 |
$6,130 |
D/D |
37,702 |
112,307 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2018-02-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,562 |
305,499 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2018-02-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,562 |
72,733 |
|
- |
|
| Wentworth Kerry |
Chief Regulatory Officer |
• – – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
12,307 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,167 |
64,728 |
|
- |
|
| Levine Mark S. |
General Counsel |
• – – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
8,333 |
|
- |
|
| Kelley Scott |
Chief Medical Officer |
• – – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
14,892 |
|
- |
|
| Bodick Neil |
Chief Scientific Officer |
• – – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
74,605 |
|
- |
|
| Kelley Scott |
Chief Medical Officer |
• – – |
2017-12-20 |
4 |
A |
$16.59 |
$14,234 |
D/D |
858 |
6,559 |
|
- |
|
| Clayman Michael D. |
President and CEO |
• • – |
2017-12-20 |
4 |
A |
$16.59 |
$2,754 |
D/D |
166 |
35,561 |
|
- |
|
| Kelley Scott |
Chief Medical OfficerOfficer |
• – – |
2017-12-06 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,334 |
|
- |
|
| Bodick Neil |
Chief Scientific Officer |
• – – |
2017-11-21 |
4 |
B |
$24.66 |
$24,656 |
I/I |
1,000 |
1,000 |
1.99 |
- |
|
| Bodick Neil |
Chief Scientific Officer |
• – – |
2017-11-21 |
4 |
B |
$24.39 |
$41,457 |
D/D |
1,700 |
64,605 |
2.74 |
- |
|
249 Records found
|
|
Page 7 of 10 |
|
|
